Your browser doesn't support javascript.
loading
RIT1 regulates mitosis and promotes proliferation by interacting with SMC3 and PDS5 in hepatocellular carcinoma.
Su, Yang; Lin, Hechun; Yu, Junming; Mao, Lin; Jin, Wenjiao; Liu, Tengfei; Jiang, Shuqing; Wu, Yunyu; Zhang, Saihua; Geng, Qin; Ge, Chao; Zhao, Fangyu; Chen, Taoyang; Cui, Ying; Li, Jinjun; Hou, Helei; Zhou, Xinli; Li, Hong.
Afiliación
  • Su Y; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
  • Lin H; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
  • Yu J; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
  • Mao L; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
  • Jin W; Department of Oncology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Liu T; Department of Oncology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200127, China.
  • Jiang S; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
  • Wu Y; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
  • Zhang S; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
  • Geng Q; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
  • Ge C; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
  • Zhao F; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
  • Chen T; Qidong Liver Cancer Institute, Qidong, 226200, China.
  • Cui Y; Cancer Institute of Guangxi, Nanning, 530021, China.
  • Li J; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
  • Hou H; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China. houhelei@qdu.edu.cn.
  • Zhou X; Department of Oncology, Huashan Hospital, Fudan University, Shanghai, 200040, China. zhouxinli@huashan.org.cn.
  • Li H; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China. hongli@shsci.org.
J Exp Clin Cancer Res ; 42(1): 326, 2023 Nov 29.
Article en En | MEDLINE | ID: mdl-38017479
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: China